Mitchell D. Nambu
Impact in
- Hepatology top 5%
- Liver physiology and pathology
- Oncology top 10%
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Biochemical and Structural Characterization 1
- Phosphodiesterase function and regulation 1
- PI3K/AKT/mTOR signaling in cancer 1
- Protein Kinase Regulation and GTPase Signaling 1
- Signaling Pathways in Disease 1
-
- Cancer Mechanisms and Therapy 2
- Co-authors
- Shinji Yamazaki (2 shared papers)Qiuhua Li (2 shared papers)Helen Y. Zou (2 shared papers)Tatiana Koudriakova (1 shared paper)Gerrit Los (1 shared paper)Steven L. Bender (1 shared paper)Joseph H. Lee (1 shared paper)Pei‐Pei Kung (1 shared paper)
- Journals
- Cancer Research (1 paper)Journal of Medicinal Chemistry (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Mitchell D. Nambu
3 papers receiving 645 citations
Mitchell D. Nambu's Hit Papers
Peers
Comparison fields: 5 of 58
- Hepatology 167
- Oncology 248
- Pulmonary and Respiratory Medicine 267
- Pathology and Forensic Medicine 103
- Cancer Research 68
Countries citing papers authored by Mitchell D. Nambu
This map shows the geographic impact of Mitchell D. Nambu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell D. Nambu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell D. Nambu more than expected).
Fields of papers citing papers by Mitchell D. Nambu
This network shows the impact of papers produced by Mitchell D. Nambu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell D. Nambu. The network helps show where Mitchell D. Nambu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitchell D. Nambu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms Hit paper breakdown → | 2007 | 617 |
| 2 | 2013 | 33 | |
| 3 | 2017 | 22 |
About Mitchell D. Nambu
Mitchell D. Nambu is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Microbiology, Hepatology and Infectious Diseases, having authored 3 papers that have together received 672 indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (2 papers), Biochemical and Structural Characterization (1 paper), Phosphodiesterase function and regulation (1 paper), Liver physiology and pathology (1 paper), PI3K/AKT/mTOR signaling in cancer (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper), Antimicrobial Peptides and Activities (1 paper) and Signaling Pathways in Disease (1 paper). The work is most often cited by research in Hepatology (167 citations), Oncology (248 citations), Pulmonary and Respiratory Medicine (267 citations), Pathology and Forensic Medicine (103 citations) and Cancer Research (68 citations). Mitchell D. Nambu has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Shinji Yamazaki, Qiuhua Li, Helen Y. Zou, Tatiana Koudriakova, Gerrit Los, Steven L. Bender, Joseph H. Lee, Pei‐Pei Kung, Barbara Mroczkowski and Maria E. Arango. Their work appears in journals such as Cancer Research, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.